The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Canadian oil producer Imperial Oil posted a rise in first-quarter profit on Friday, driven primarily by stronger margins in ...

Britain's blue-chip index notched its 15th consecutive session of gains - its longest winning streak on record - as investors ...

In 2023, experts decided against adding obesity drugs to the World Health Organisation's essential medicines list.

Viking is developing what might be a game-changing medication in the segment.

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

Young US women with breast cancer are not dying from the disease as often as a decade ago, researchers reported at the ...

Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

More than a billion people now have obesity worldwide, according to the WHO, and around 70% of them live in low and ...

Anthropic is preparing to carry out its first employee share buyback, valuing the firm at $61.5 billion. The initiative also ...

The U.S. financial regulator's approval last month of a proposal by the world's largest meatpacker JBS to list on the New ...